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AbstrAct
Purpose Reticular pseudodrusen (RPD) are a risk 
factor for late age-related macular degeneration (AMD). 
Associations between RPD and coronary artery disease 
(CAD) have been reported from small case–control 
studies. This study investigated the association of RPD 
within a predominantly CAD cohort.
Methods A subgroup of subjects from a multicentre 
randomised controlled trial of CT coronary angiography 
(CTCA) underwent ultrawide field (UWF) retinal imaging 
CAD determined by CTCA and was categorised as 
normal, non-obstructive or obstructive. Specific AMD 
features in UWF images were graded. Standardised 
grids were used to record the spatial location of AMD 
features, including RPD. Multivariate confounder adjusted 
regression models assessed the association between RPD 
and CAD.
results The 534 participants were aged 27–75 years 
(mean 58±9 years; 425 (80%) ≥50 years) with a male 
preponderance (56%). Within the study sample, 178 
(33%) had no CAD, 351 (66%) had CAD. RPD was 
detected in 30 participants (5.6%) and bilaterally in 23. 
Most participants with bilateral RPD had intermediate 
AMD 17 (74%). After adjustment for potential 
confounders (age, sex, drusen >125 µm, smoking status), 
multivariate analysis found no significant association 
between CAD and RPD (OR 1.31; 95% CI (0.57 to 
3.01); p=0.52). A significant association was identified 
between RPD and intermediate AMD (OR 3.18; 95% CI 
(1.61 to 6.27); p=0.001).
conclusion We found no evidence to support an 
association between CAD and RPD. RPD was strongly 
associated with intermediate AMD features.
trial registration number NCT01149590, Post 
results.
IntroductIon
Age-related macular degeneration (AMD) is the 
leading cause of permanent blindness in the devel-
oped world with the most sight loss occurring in the 
late stages, namely geographic atrophy (GA) and 
choroidal neovascularisation (CNV).1 Risk factors 
for progression from early to late AMD include 
advancing age, cardiovascular disease (CVD), 
obesity, cigarette smoking, ethnicity, hypertension, 
high cholesterol, genetic variants such as age-re-
lated maculopathy susceptibility 2 (ARMS2) gene, 
complement factor H (CFH) and apolipoprotein 
E (ApoE) gene and inflammatory markers such as 
C-reactive protein.2 Recently, reticular pseudod-
rusen (RPD) have been shown to be an important 
independent risk factor for progression to both 
GA3 4 and CNV.3 5 In addition, various risk factors 
have been reported to be associated with RPD 
including advancing age, female gender, smoking, 
ARMS2, complement component 3 (C3), vascular 
endothelial growth factor A (VEGFA) and CFH 
genetic variants.6–8
RPD is a subtype of AMD associated with 
subretinal drusenoid deposits (SDD) and is located 
between the retinal pigment epithelium (RPE) and 
the inner ellipsoid zone.6 Associations between 
RPD, SDD, reticular macular disease and coronary 
artery disease (CAD) have been reported from small 
case–control studies. The acronyms and associated 
full titles are mentioned here in order to avoid any 
confusion. In particular, the term SDD is preferred 
for the actual physical deposits as first recognised 
within histopathology by Curcio et al.9
In association with the selection of image 
modality, variations in specific definitions of RPD 
have also led to substantial differences in reported 
prevalence rates. Initial reports of the association 
came from data collected on AMD cohorts recruited 
in hospital eye clinics and reported high prevalences 
ranging from 29% to 52%.6 10 11 Data from popula-
tion-based studies are limited and show large varia-
tion, such as 0.4% from the Melbourne Collabora-
tive Cohort study to 4.9% in the Rotterdam study 
and 13% in the Alienor study.7 8 12 Such varying esti-
mates might be attributed to the different imaging 
and grading protocols used.
The strong association between RPD and a thin 
choroid has prompted a spate of small studies 
that have sought associations between RPD and 
CVD.13–17 Cymerman et al reported on a small 
prospective cohort of patients with no known 
retinal disease recruited from a cardiovascular 
clinic; 23 participants with CAD had a higher 
frequency of RPD compared with 15 who did not 
have CAD.13 A review by Rastogi and Smith14 on 
the association between AMD, RPD and CVD high-
lighted studies reporting an association between 
RPD and hypertension and angina.15–18 Smith 
and colleagues hypothesised that the increased 
mortality from systemic-vascular disease that 
affects men more severely compared with women, 
may account for the higher proportion of women 
with RPD that has been observed in various 
population-based studies.18 Notably, this review 
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highlighted the potential importance of large prospective cohort 
studies sampling participants >45 years with and without CAD 
to identify RPD development and potential associations.14
A substudy of the SCOT-HEART (SH) trial that incorporated 
only ultrawide field (UWF) retinal imaging offered a unique 
opportunity to explore the relationship between CAD and RPD. 
The use of wide field technology to evaluate the retinal fundus 
offered an additional advantage as RPD is commonly located 
in the retinal arcades and beyond.15 To date, there is one study 
that has estimated RPD prevalence that has included central and 
peripheral retinal locations.19 In this study, RPD were present in 
15% of subjects with AMD in zone 2, but none in the controls, a 
difference that was significant. However, the sensitivity of UWF 
to detect RPD has not been established. We therefore first vali-
dated the methodology using images from a population-based 
epidemiological study (the Northern Ireland Cohort for the 
Longitudinal Study of Ageing (NICOLA)) which captured UWF, 
colour fundus photography (CFP), infrared (IR) and autofluo-
rescence (AF) images of the retina, and subsequently used the SH 
trial substudy UWF images to explore the relationship between 
RPD and CAD.
MAterIAls And Methods
Validation of detection of rPd by uWF imaging
Nine hundred consecutive participants were selected from the 
NICOLA study. CFP was performed on the Canon CX-1 Digital 
Fundus Camera (Canon USA, Melville, NY, USA). Stereoscopic 
pairs centred on the optic disc and macula were captured. CFP 
images were viewed and graded using the Oculab program 
(Digital Healthcare Oculab, V3.7.98.0; Emis Health, Leeds, UK). 
UWF retinal imaging was performed on the Optos Tx200 Scan-
ning Laser Ophthalmoscope (Optos, Dunfermline, UK) using 
both colour and AF acquisition modes. Images were viewed and 
graded using the Optos V2 Vantage Pro software (V.2.9.4.2).
UWF images were graded for the presence or absence of RPD 
by a trained single grader who was not involved in any other 
grading procedures with quality assurance and reviewed by a 
retina specialist (UC). All available imaging modalities were used 
to determine the presence of RPD. This included en face images 
of colour, multicolour, AF and IR. In addition, high-resolution 
optical coherence tomograms were also scrutinised for the pres-
ence of SDD. The image grading was undertaken by trained 
graders in the network of UK Reading Centres (NetwORC 
UK) for the presence or absence of RPD. Detection of RPD on 
any modality was taken as evidence of presence of this feature. 
Sensitivity and specificity of the UWF imaging in detecting RPD 
compared with the RPD detected from the NICOLA cohort’s en 
face and tomographic images were computed.
the sh study and sample
The SH trial ( ClinicalTrials. gov, number NCT01149590) was a 
multicentre randomised controlled trial undertaken in Scotland 
(2010–2014) on 4146 participants, aged 18–75 years, drawn 
from 12 cardiology clinics across Scotland.20 The main aim of 
the study was to determine the role of multidetector CT in the 
diagnosis and management of patients attending rapid access 
chest pain clinics. Participants were randomly assigned to either 
standard care (control intervention) or standard care and the 
CT coronary angiography (CTCA) and calcium scores (interven-
tion). CAD was categorised in the SH study as: (1) obstructive 
CAD, atherosclerotic plaque encompassing a luminal cross-sec-
tional area of ≥70% in at least one major epicardial vessel; (2) 
non-obstructive CAD, either atherosclerotic plaque encom-
passing a luminal cross-sectional area of <70% but >10% in at 
least one major epicardial vessel, or a calcium score >400 AU 
(Agatston units) or >90th percentile for age and sex; or (3) 
minimal or no CAD. Non-obstructive disease was further subdi-
vided into mild (10%–50% luminal cross-sectional area) or 
moderate (50%–70% luminal cross-sectional area) stenosis. At 
two sites (Edinburgh and Dundee), consecutive patients were 
approached to undergo UWF imaging immediately before or 
after undergoing CTCA. We assessed 534 participants from 
a substudy of SH who had UWF imaging captured using two 
Optos P200C Scanning Laser Ophthalmoscopes (Optos) in 
addition to the normal study procedures at two sites (the Clin-
ical Research Imaging Centre in Edinburgh and the Clinical 
Research Centre Dundee).21
Image grading in sh
Specific features of AMD in UWF images were graded for AMD 
characteristics (increased pigment, decreased pigment, drusen, 
maximum drusen size, RPD, GA and CNV) and other periph-
eral abnormalities using the ‘Study-specific Grading Procedures 
for OPERA Study’ guidelines (November 2013).22 The Optos 
software used a modified Studies of Ocular Complications of 
AIDS (SOCA) Optos PEripheral RetinA study (OPERA) grid 
(figure 1) which was divided into three zones: zone 1 (poste-
rior pole), zone 2 (extends from Z1 to a circle through the 
ampullae of the vortex veins) and zone 3 (extends from Z2 to 
the outer periphery). The Manchester grid was superimposed 
on the SOCA grid to estimate the ungradable areas (figure 2). 
In accordance with the OPERA guidelines, at least 50% of the 
subfield should be visible to grade; if <50% of the subfield was 
visible, it was graded as ‘Cannot Grade.’ If AMD characteristics 
and other pathologies were present in a Cannot Grade subfield, 
and if the grader was ≥90% certain the lesion was present, then 
grading was ascribed. Drusen presence was graded as follows: 
absent; questionable; 1–5 drusen; 6–20 drusen; >20 drusen or 
cannot grade. The maximum drusen size was graded as follows: 
<125 µm; ≥125 µm, <250 µm distinct; ≥125 µm, <250 µm 
indistinct; ≥250 µm distinct; ≥250 µm indistinct or cannot 
grade. RPD was graded as follows: absent; questionable; <25% 
of subfield; 25%–49% of subfield; 50%–74% of subfield; ≥75% 
of subfield or cannot grade. RPD were defined as yellow inter-
lacing networks ranging from 125 µm to 250 µm in width or 
lesions that occurred in regular well-defined domains (figure 3). 
Images in which RPD were questionable were arbitrated by a 
retinal specialist (UC).
statistical analysis
Statistical analyses were performed using IBM SPSS Statistics 
V.20. Intraobserver agreement was calculated after 1 in 20 of the 
images was randomly regraded for RPD and drusen using kappa 
(k) statistics, which express the extent of agreement beyond 
chance. The interpretation of the k statistic was as follows: 0, no 
agreement; 0–0.2, slight agreement; 0.21–0.40, fair agreement; 
0.41–0.60, moderate agreement; 0.61–0.8, substantial agree-
ment; and >0.81, almost perfect agreement.23
Univariate analysis (χ2 test or Fisher’s exact test for categor-
ical variables and independent t-test for continuous variables) 
was used to examine differences in the demographic character-
istics of participants according to presence or absence of RPD. 
General estimating equations (GEE) which enabled data from 
both eyes to be included were used to examine the association 
between RPD and CAD while accounting for other factors iden-
tified as significant from the univariate analysis.
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results
Validation study
The sensitivity and specificity of UWF were compared with 
en face and tomographic multimodal images in the detection of 
RPD. Of the images acquired from the 900 consecutive partici-
pants included in the validation study, UWF imaging detected eight 
participants with reticular drusen (two unilateral and six bilateral; 
100% sensitivity). Multimodal imaging (colour, multicolour, IR 
and AF and optical coherence tomography) detected RPD in seven 
of those which were seen on en face images. The specificity of the 
UWF imaging was 99.9%. In one case, the UWF imaging detected 
RPD beyond the field of view captured by the combination of 
retinal imaging (figure 4). The positive predictive value was calcu-
lated at 87.5% and the negative predictive value was 100%.
Figure 1 The modified Studies of Ocular Complications of AIDS grid used on the Optos software. Z1 and Z2 are each divided into four quadrants: 
superonasal (SN), superotemporal (ST), inferotemporal (IT) and inferonasal (IN). Z3 is divided into two hemispheres (superior, inferior) using a visual 
extension of the horizontal cross line (yellow dashed lines). (Taken from the Study-specific Grading Procedures for Optos PEripheral RetinA study, 
University of Wisconsin (2013)).22
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Participant characteristics in sh study
Table 1 summarises SH study participant characteristics. In total, 
534 individuals had UWF retinal images captured. Two partic-
ipants (four eyes) proved difficult to scan and images were not 
obtained. This left 532 pairs of eyes for grading. The mean age 
was 58 years (range=27–75, SD 9.5) with 425 (80%) aged over 
50 years. There were 299 men (56%). A total of 178 (33%) had 
no CAD, 351 (66%) had CAD present, while 182 (34%) had 
hypertension and 42 (24%) had no CAD or hypertension.
The intragrader agreement illustrated in table 2 gives the 
kappa range for the AMD features: for the presence of RPD 
it ranged from: 0.62–0.76; for drusen: 0.58–0.64, maximum 
Figure 2 Optos ultrawide field retinal image grading grids for specific 
age-related macular degeneration characteristics. The SOCA grid is 
divided into three zones: zone 1 (posterior pole), zone 2 (extends 
from Z1 to a circle through the ampullae of the vortex veins) and 
zone 3 (extends from Z2 to the outer periphery). The Manchester 
grid was superimposed onto the SOCA grid to assess the ungradable 
areas. SOCA, Studies of Ocular Complications of AIDS.
Figure 3 Optos UWF retinal image illustrating RPD. The appearance of RPD on UWF is described as an interlacing reticular pattern, which appear 
superiorly in the outer macula and extend circumferentially and further. RPD, reticular pseudodrusen; UWF, ultrawide field.
Figure 4 The RPD interlacing pattern on both the UWF and fundus 
camera image. (A) UWF pseudocolour image showing RPD (black 
circle). (B) UWF green laser imaging with RPD visible within the black 
circle. (C) Fundus camera image with RPD within the black circle. (D) 
UWF pseudocolour image with arrows pointing to areas of RPD. (E) 
UWF green laser imaging with arrows annotating areas of RPD. In 
this case, RPD was detected beyond the field of view of colour fundus 
photography. (F) Corresponding fundus camera image with no readily 
visible RPD within the black circle. RPD, reticular pseudodrusen; UWF, 
ultrawide field.
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drusen size: 0.55–0.62, increased pigment: 0.54–0.61, decreased 
pigment: 0.55–0.62; for GA: 0.62–0.76; for neovascular AMD: 
0.57–0.66 and for peripheral abnormality: 0.55–0.59 within 
zones 1–3. For the lesions which were absent in the cohort the 
discordance in the grading originated from a change of grade of 
feature absent to ungradable between the two gradings.
Prevalence of rPd and AMd features in the sh study
RPD was present in one or both eyes of 30 participants (5.6%) 
and bilateral in 23 participants (4.3%). Intermediate AMD 
was present in 201 participants (38%). Participants with RPD 
ranged in age from 33 to 75 years (mean 59) and there were 
equal numbers of men and women. The other AMD features 
graded as present in the participants were as follows: 352 (66%) 
had hyperpigmentation, 55 (10%) had hypopigmentation, 2 
(0.4%) had unilateral GA, none of the participants was classified 
as having neovascular AMD and 183 (34%) showed other 
non-AMD peripheral abnormalities.
Association of cAd with rPd
CAD was present in 20 participants and absent in 10 partici-
pants with RPD; however, no statistically significant association 
between RPD and CAD was found on either the unadjusted or 
adjusted GEE model (p>0.05, table 3). With respect to associa-
tions between RPD and other early AMD features, a strong asso-
ciation was noted with intermediate AMD in the fully adjusted 
model (OR 3.18; 95% CI (1.61 to 6.27); p=0.001). Eighteen 
participants had both RPD and intermediate AMD, while 11 
participants had RPD alone without evidence of soft drusen.
dIscussIon
We believe that our study is the first to report on the prevalence 
of RPD using UWF retinal images in patients with confirmed 
CAD. Contrary to previous reports, our study did not reveal 
a significant association between RPD and CAD.13–16 18 Detec-
tion of RPD was based on retinal wide field imaging and was 
graded using standardised protocols. We validated the ability 
of UWF colour images to detect RPD by checking agreement 
within a set of images acquired using multimodal technology and 
demonstrated that UWF was reliable, reproducible and robust. 
Our findings are in accordance with population-based studies 
and some of the clinical cohorts that did not report significant 
associations between RPD and CAD or hypertension.6–8 12 24 In 
fact, the prevalence of RPD observed in the current SH study 
(30 out of 534 participants—5.6%) is similar to that reported 
by the population-based Rotterdam study (4.9%),7 providing 
additional support for the view that CAD is not associated with 
an increased prevalence of RPD. Interestingly, Zarubina et al 
studied patients from primary care eye clinics with and without 
AMD, and using multimodal imaging and strict criteria found 
that the prevalence of SDD in subjects without AMD was 23%. 
However, using expanded criteria, Zarubina et al discovered 
that the prevalence of SDD on any modality, closest to that of 
the current study, rose to 69% in subjects  with a mean age of 
~68 years. In comparison, the population in the current study 
had a mean age of ~58 years, and an SDD prevalence of only 
5.6%. This is a large difference in prevalence, as Zarubina et al 
used SD-OCT, whereas this study only used UWF, and RPD is 
better detected on SD-OCT, so it would be expected to have a 
lower prevalence on UWF.24
While 80% of participants were aged over 50, a common age 
restriction for many AMD studies, interestingly eight partic-
ipants with RPD were aged under 50, the youngest aged 33. 
table 1 Summary statistics for study participants
All 
participants
n=534
reticular pseudodrusen (one or 
both eyes)
Absent
n=504
Present
n=30) p
Age 0.76
Mean (SD) 58 (10) 58 (9) 59 (12)
Sex (%) 0.57
  Male 299 (56) 284 (56) 15 (50)
  Female 235 (44) 220 (44) 15 (50)
Body mass index 0.19
Mean (SD) 30 (7) 30 (7) 28 (6)
CAD diagnosis (%) 0.71
  None 178 (33) 168 (33) 10 (33)
  Non-obstructive to mild 114 (21) 105 (21) 9 (30)
  Non-obstructive to moderate 87 (16) 84 (17) 3 (10)
  Obstructive CAD 150 (28) 142 (28) 8 (27)
  Missing 5 (1) 5 (1) 0 (0)
CAD (%) 0.99
  Absent 178 (33) 168 (33) 10 (33)
  Present 351 (66) 331 (66) 20 (67)
  Missing 5 (1) 5 (1) 0 (0)
Assign score 0.56
Mean (SD) 18 (12) 18 (12) 17 (11)
Coronary artery calcium score 0.67
Mean (SD) 314 (805) 310 (814) 376 (634)
Hypertension (%) 0.84
  No 346 (65) 327 (65) 19 (63)
  Yes 182 (34) 171 (34) 11 (37)
  Missing 6 (1) 6 (1) 0 (0)
Diabetes (type 1 or 2) (%) 0.76
  No 483 (90) 455 (90) 28 (93)
  Yes 51 (10) 49 (10) 2 (7)
Drusen >125 µm (%) 0.01
  Absent 330 (62) 319 (63) 11 (37)
  Present 201 (38) 183 (36) 18 (60)
Missing 3 (1) 2 (1) 1 (3)
Smoking history (%) 0.25
  Never 256 (48) 244 (48) 12 (40)
  Ex-smoker 193 (36) 183 (36) 10 (33)
  Current smoker 85 (16) 77 (15) 8 (27)
CAD, coronary artery disease.
table 2 Intragrader agreement for the individual AMD phenotypes
AMd characteristic
Kappa range
Zone 1 Zone 2 Zone 3
Neovascular AMD 0.66 0.57 0.61
Increased pigment 0.59 0.54 0.61
Decreased pigment 0.66 0.55 0.62
Geographic atrophy 0.66 0.76 0.62
Drusen 0.59 0.64 0.58
Maximum drusen size 0.60 0.62 0.55
Reticular pseudodrusen 0.67 0.76 0.62
Peripheral abnormality   NA 0.59 0.55
Presence of other pathology (all zones) 0.62
AMD, age-related macular degeneration; NA, not applicable.
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Of these, four (50%) also had evidence of intermediate AMD 
whereas the rest had no other features of AMD present. If, as 
has been proposed, the primary lesion is vascular (choroidal 
insufficiency), then as the disease progresses the development 
of SDD may follow. It is possible that this may be one expla-
nation for the findings of fewer SDD within a younger popula-
tion. In the overall sample, seven participants had RPD without 
any other AMD features similar to previous observations,7 
which may reflect a different phenotype given that RPD have 
been reported in other retinal diseases such as Sorsby fundus 
dystrophy, pseudoxanthoma elasticum and acquired vitelliform 
lesions.25–27 Given the rarity of these participants, it is likely that 
studies of large sample size or pooled analyses across studies will 
be required to improve our understanding of the relevance of 
these isolated RPD.
The RPD phenotype in AMD has been shown to be associ-
ated with choroidal thinning28–33 and thus it has been suggested 
that RPD arise as a consequence of choroidal vascular pathology 
such as age-related atherosclerosis. Interestingly, Leisy et al 
recently found an association between the RPD phenotype and 
renal dysfunction.34 However, we were unable to establish a 
relationship in a large population with a diagnosis of CAD that 
was established using robust methodology and which constitutes 
an important marker for systemic vascular disease. Therefore, 
we contend that the pathogenesis of RPD remains unresolved 
and we suggest that the outer photoreceptor mosaic may be the 
source of this material which in turn is a consequence of RPE 
degeneration with withdrawal of trophic/survival factors to the 
photoreceptors.
This is only the second study, to our knowledge, that used 
UWF imaging for the evaluation of RPD.19 Using the NICOLA 
image repository we confirmed the reliability of this approach 
to detect reticular drusen which have been observed when 
using other en face modalities such as IR or AF imaging. None-
theless, we are of the view that as with other en face modali-
ties, UWF imaging also underestimates the prevalence because 
the earliest stages of the SDD phenotype are best appreciated 
on high-resolution SD-OCT.35 Stage 1 SDD is defined by the 
dispersed nature of the deposits of granular hyper-reflec-
tive material that is present in the outer retina in the region 
of the photoreceptors’ inner and outer segments (the IS/OS 
boundary) and the RPE. A characteristic reticulated pattern 
accompanies stages 2 and 3, which has been attributed to focal 
deposits that cause marked alterations to the IS/OS boundary 
and thus become detectable by en face imaging.35 Currently, it 
is accepted that detection of RPD is best when a multimodal 
approach, combining IR, AF and SD-OCT, is used.12 36 We 
were however reassured by the validation study which demon-
strated the benefit of the increased field of view provided by 
UWF imaging. We also noted that RPD was evident in at least 
one participant in an area of the retinal fundus that is typically 
not included in colour images (35° or 45°) or OCT, raising the 
possibility of under ascertainment when the field of examina-
tion is restricted to the central fundus.
A potential limitation of this study is the choice of controls as all 
participants (cases and controls) were recruited from cardiology 
clinics. However, control status was only assigned following an 
extensive and robust clinical examination, CTCA and calcium 
scores. This cohort may therefore have characteristics that are 
dissimilar from that of a random population-based sample. Even 
though we adjusted for age, sex and smoking habit, some of the 
established AMD risk factors, such as diet, and genetic risk, were 
not available and therefore residual confounding may have been 
present. However, concerns over residual confounding are less 
worrisome, given the absence of the finding of a positive associ-
ation between CAD and RPD.
In conclusion, our study does not support previously reported 
associations with CAD. As with other studies, we observed the 
strong association with the hallmark feature of classical drusen 
which is recognised as early AMD. Our findings highlight the 
necessity for other studies in this age group with improved 
phenotyping of the ocular fundus as well as vascular disease in 
other organ systems. Data from large and well-characterised 
longitudinal population-based studies with multimodal imaging 
will be required. In addition, pooled analyses of multiple studies 
to improve statistical power may help untangle the complexity 
of the risk factors and subphenotypes involved.
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table 3 Investigation of CAD as a risk factor for reticular pseudodrusen using generalised estimating equations.
unadjusted model Age and sex adjusted Multivariate adjusted*
or 95% cI p or 95% cI p or 95% cI p
CAD 1.30 0.58 to 2.92 0.52 1.33 0.57 to 3.11 0.52 1.31 0.57 to 3.01 0.52
Age 1.01 0.95 to 1.07 0.78 1.00 0.95 to 1.06 0.92
Sex 1.51 0.67 to 3.40 0.32 1.40 0.62 to 3.14 0.42
Drusen >125 µm 3.18 1.61 to 6.27 0.001
*Multivariate model was adjusted for age, sex and smoking status.
CAD, coronary artery disease.
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